NASUS PHARMA LTD
NSRX·M7071P109·US·Common Stock·Healthcare - Drug Manufacturers - General-13D/G
NSRX (NASUS PHARMA LTD) is held by 6 institutional investors as of Q2 2026. Largest holders: BALYASNY ASSET MANAGEMENT L.P. ($3.1M), Hudson Bay Capital Management LP ($471,699), CITADEL ADVISORS LLC ($77,014). Net institutional sentiment: Mixed.
6
Holders
$3.8M
Total Value
50% (6)
Consensus
3 buying - 3 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 12, 2026 · Insiders Jun 22, 2026 · Activists Aug 14, 2026 · Congress none
InsiderTBTeleman Dan BenjaminBuy $20KJun 17, 2026
Checking access…
Top Holders
Checking access…
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer